Entries by blueoxygen

1 May 2017

Paris, France, May 1, 2017 — Prof. Andrew Coats of Monash and Warwick Universities presented today at a late breaking trials session of the Heart Failure 2017 congress the 18-month and 2-year follow-up results of the AUGMENT-HF trial.  AUGMENT-HF is a multicentric randomized clinical study to evaluate the safety and efficacy of Algisyl, an implantable […]

11 November 2015

LoneStar Heart Reports Successful One-Year Results of Randomized Clinical Trial on Efficacy of Algisyl® in the Treatment of Heart Failure

Significant Patient Improvements Reported at American Heart Association’s Late-Breaking Trials and Published in the European Journal of Heart Failure

18 November 2014

LoneStar Heart Reports Significant Improvement in Health Status of Advanced Heart Failure Patients Treated with Algisyl-LVR® Cardiac Hydrogel Implants

Outcomes of the AUGMENT-HF Trial of Algisyl-LVR for Advanced Heart Failure Patients Presented at American Heart Association’s Clinical Science Special Reports

01 October 2014

LoneStar Heart Receives European Approval to Market its Algisyl-LVR® Hydrogel Implant for the Treatment of Advanced Heart Failure

Implantable Gel May Revolutionize the Treatment of Patients Who Lose the Ability to Pump Blood Efficiently to the Body

05 May 2014

LoneStar Heart Completes Recruitment for Randomized Clinical Trial of Algisyl-LVR® Hydrogel Implant for Advanced Heart Failure

Six-month Outcomes of AUGMENT-HF Multicenter Study to Be Presented by Yearend